- Home
- WINT vs CEAD Comparison
WINT vs CEAD Comparison
Compare WINT & CEAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WINT
- CEAD
- Stock Information
- Founded
- WINT 1992
- CEAD 2009
- Country
- WINT United States
- CEAD United States
- Employees
- WINT N/A
- CEAD N/A
- Industry
- WINT Biotechnology: Biological Products (No Diagnostic Substances)
- CEAD Industrial Machinery/Components
- Sector
- WINT Health Care
- CEAD Industrials
- Exchange
- WINT Nasdaq
- CEAD Nasdaq
- Market Cap
- WINT 5.3M
- CEAD 5.6M
- IPO Year
- WINT 1995
- CEAD N/A
- Fundamental
- Price
- WINT $0.50
- CEAD $6.00
- Analyst Decision
- WINT Hold
- CEAD
- Analyst Count
- WINT 1
- CEAD 0
- Target Price
- WINT $18.00
- CEAD N/A
- AVG Volume (30 Days)
- WINT 549.5K
- CEAD 10.1K
- Earning Date
- WINT 11-26-2024
- CEAD 11-14-2024
- Dividend Yield
- WINT N/A
- CEAD N/A
- EPS Growth
- WINT N/A
- CEAD N/A
- EPS
- WINT N/A
- CEAD N/A
- Revenue
- WINT N/A
- CEAD $2,637,116.00
- Revenue This Year
- WINT N/A
- CEAD N/A
- Revenue Next Year
- WINT N/A
- CEAD N/A
- P/E Ratio
- WINT N/A
- CEAD N/A
- Revenue Growth
- WINT N/A
- CEAD N/A
- 52 Week Low
- WINT $0.45
- CEAD $5.22
- 52 Week High
- WINT $22.32
- CEAD $11.04
- Technical
- Relative Strength Index (RSI)
- WINT 27.72
- CEAD 29.75
- Support Level
- WINT $0.45
- CEAD $5.60
- Resistance Level
- WINT $0.64
- CEAD $6.61
- Average True Range (ATR)
- WINT 0.06
- CEAD 0.30
- MACD
- WINT 0.07
- CEAD -0.08
- Stochastic Oscillator
- WINT 19.50
- CEAD 24.67
About WINT Windtree Therapeutics Inc.
Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.
About CEAD CEA Industries Inc.
CEA Industries Inc through its subsidiary is focused on selling environmental control and other technologies and services to the Controlled Environment Agriculture ("CEA") industry. The company provides integrated mechanical, electrical, and plumbing ("MEP") engineering design, proprietary and curated environmental control equipment, and automation offerings that serve the CEA industry. The Company has one operating segment that is dedicated to the manufacture and sale of its products.